df-mp - News

News Reader As part of our service for our clients, we provide information regarding the latest developments in intellectual property matters as well as noteworthy news about df-mp.

Firm News

Litigating Patents under the UPC System - IAM Patents in Europe 2018/2019

In association with the EPO, Sandra Pohlman, Philipp Nordmeyer and Dominik Ho from df-mp contributed an article entitled "Litigating Patents under the UPC System" to the IAM Guide "Patents in Europe: Helping business compete in the global economy 2018/2019" (a supplement to IAM, published by Globe Business Media Group - IP Division).
The article can be accessed via the following link.
(Download of the Article in PDF Format).

To view the IAM guide in full, please go to www.IAM-media.com.

"Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs" (UCL / Georgetown Law, February 8 & 9, 2018 in Washington, D.C.)

In February 2018, Dr. Michael Eder was an invited speaker at the event "Clinical Innovation: Fair and Effective Incentives for New Uses of Established Drugs", co-organized by Sir Robin Jacob (University College London) und Prof. Jay Thomas (Georgetown Law). Dr. Eder gave a presentation on the EPO's take regarding the concept of plausibility in patent applications.
The presentations, session transcripts, speaker biographies and session topics can be found on the website of the University College London(Link to UCL Event Site).

df-mp is proud to be an associate sponsor of the C5 Life Sciences IP Summit 2017 which will take place in Munich on October 11 and 12, 2017

More information regarding this event may be found here.

Presentation by Audrey Nemeth on March 3, 2016 in Munich

Audrey Nemeth will be giving a presentation on "US Patent Law for European Patent Professionals" at the legal reference bookstore "Schweitzer Sortiment" on March 3, 2016 in Munich.
(download invitation)

Start of the Intellectual Property Magazine

The Intellectual Property Magazin (IPM), the most recent member of the family of online magazines of German Law Publishers (GLP), had a successful start. IPM is directed to legal departments, law firms and the legal community generally and offers topics that are relevant to IP practice by authors from both the legal profession and academia. df-mp supports the IPM as one of several partners inter alia by virtue of corresponding articles. For example, in the first edition of Juli 1, 2015, Dr. Holger Schimmel and Dr. H. Ulrich Dörries of df-mp discuss first conclusions from recent decisions in Germany, England and the Netherlands regarding patent infringement of second medical use claims via so-called "skinny labels", i.e., product information where the patent protected indication has been carved out.

Free subscriptions of the IPM are available to interested users.

Prestigious JUVE Award as "Law Firm of the Year for Patent Law" bestowed to df-mp

Each year, the German JUVE commercial law publishing company assigns the eponymous JUVE Award to carefully selected law firms and in-house teams in Germany. The nominations and selections are based on the extensive research of the JUVE editorial staff for the annual JUVE Handbook of German Commercial Law Firms.

The awards were announced on 23 October 2014 during a festive awards ceremony at the old Opera House in Frankfurt.

"Building outstanding litigation expertise in several industry sectors - this had so far not been achieved by a German Patent Law Firm. But the Munich-based patent attorneys of df-mp did succeed: They are very active in both, mobile communications and pharma litigation matters and thus set the currently most important trend of their profession. [...]
Basis for their impressive development is the very active patent prosecution practice of the meanwhile 14
[as of Oct 2014: 19]qualified Patent Attorneys."
(JUVE Handbook 2014/15 (German version), P. 486, Laudation Law Firm of the Year 2014 for Patent Law)

"Overall the well-regarded patent law firm is, despite their active patent prosecution practice, leaning towards litigation matters. Lately their attorneys managed to considerably increase their visibility in patent litigation cases.[...]
Regardless of the technical field, litigation firms increasingly use their patent attorneys as technical support in infringement matters. (JUVE Law Firm of the Year)"

(JUVE Handbook 2014/15 (German version), P. 491)

David Molnia represents patent holder in a mock trial at the "EPO Board of Appeal and key decisions Seminar" organized by the European Patent Academy

As part of the EPO Board of Appeal and key decisions 2014 Seminar, which was attended by more than 300 patent law practitioners, the European Patent Academy (http://www.epo.org/about-us/office/academy.html) conducted a mock trial to give participants an insight into oral proceedings before the boards of appeal. The participants of the mock trial included current and former members of the Boards of Appeal. David represented the Respondent and Patent Proprietor.

Rainer Friedrich contributed an essay in "Mitteilungen der deutschen Patentanwälte" (#7 /2014) regarding the "reading-along" of information not literally disclosed in a document by the skilled person. (download)

In "Getting the Deal Through - Patents"[Accreditation] df-mp advises on obtaining and enforcing patents in Germany

The German chapter of "Getting the Deal Through-Patents 2015" (download).

df-mp is now a partnership with limited professional liability (PartG mbB)

Effective February 11, 2014, df-mp is a partnership with limited professional liability (PartG mbB), registered under no. PR 1278 on the partnership register of the Local Court Munich (AG München). This form of partnership was created by the amendment of July 19, 2013 to the German partnership act (PartGG) and is comparable to a Limited Liability Partnership (LLP) in the UK.

Clients of df-mp will now benefit from a legally-based, very high level of insurance coverage. Every partnership with limited liability is required to carry a high minimal level of professional liability insurance. The minimum insurance coverage for a partnership with limited liability is 2.5 million Euros for each insurance claim, whereas previously the minimum insurance coverage for each insurance claim was only 250,000 Euros. Above this minimum amount, the df-mp limited liability partnership has secured an insurance coverage of up to 10 million Euros per insurance claim.

As part of the conversion to the PartG mbB the name of the firm has changed. As of February 11, 2014, the full name of our firm is:

df-mp Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB

Please note that all future client matters will be handled by df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB.

Moreover, kindly note that existing client matters handled by df-mp are now handled by df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB.

We are at your disposal for any further information with regard to this change.

df-mp at "C5's 26th Forum of Biotech Patenting" March 26 and 27, 2014 in Munich
df-mp is proud to announce that it is an associate sponsor of the 26th Forum on Biotech Patenting to be held on March 26-27, 2014 at the Hotel Vierjahreszeiten in Munich.
Two of the firm's partners will also feature as speakers on important topics in the biotechnology field. Rainer Friedrich will present his views on issues arising in connection with broad claims, while Sandra Pohlman will be giving a presentation on the newest legal developments in the field of Supplementary Protection Certificates (SPCs).
(download conference brochure)

Presentation of Elisabeth Greiner on C5's upcoming FTO conference, May 14 and 15, 2014 in Munich

Elisabeth Greiner will be giving a presentation at the upcoming C5 conference "Freedom to Operate" to be held on May 14 and 15, 2014 in Munich. She will speak on the topic of "Practical Steps to Tailor your FTO strategy in Response to the Latest SPC Case Law".
(download conference brochure)

IAM magazine names df-mp as recommended firm for patent prosecution and patent nullity actions in Germany 2014 - Dr. H. Ulrich Dörries and Sandra Pohlman also listed individually as "recommended experts"

We are pleased to announce that df-mp, Dr. Dörries and Sandra Pohlman have once again been named in IAM Magazine's most recent publication "IAM 1000 - The World's Leading Patent Practitioners 2014" as "recommended law firm" and "recommended expert" in Germany. IAM lists df-mp as one of the top recommended firms for patent nullity actions and patent prosecution.

In "IAM 1000 - The World's Leading Patent Practitioners 2014" IAM writes about df-mp:

"Fast making a name for itself, dynamic boutique df-mp has become something of a mover and shaker on the German market. It counts lawyers qualified to practise in both the US and EU systems among its talented team, and offers a distinctly global perspective. The full suite of patent services is provided, although opposition work is a specialty. “Its pharmaceutical and chemistry group is home to some very responsive and experienced litigators”, who have attracted the attention of heavyweight clients such as MYLAN and Teva Pharmaceutical Industries Ltd. [...]"

Please refer to the links for more details on IAM's recommendation of the firm, Dr. Dörries and Sandra Pohlman.

df-mp – IP News

European Patent Office will amend Rule 164 EPC as from November 1, 2014 and allow requests for further searches in cases of lack of unity

Under amended Rule 164 EPC it will be possible for the applicant to pay, within a period of two months, one or more further search fees in respect of any unsearched inventions claimed upon entry into the European phase in order for these to be covered by a further search. Thereafter, the applicant may select any invention searched by the EPO for further prosecution of the application. This option is available both if a supplementary European search must be carried out (the EPO was not the (S)ISA) and if the supplementary European search is dispensed with because the EPO acted as (S)ISA for the application concerned.

The European Patent Office (EPO) repeals the 24-month time limit for filing divisional applications

The European Patent Office (EPO) officially announced on October 18 its decision to repeal the 24-month deadline of rule 36 EPC for filing divisional applications. The change goes into effect on April 1, 2014 and applies to all applications pending at that time. The change reverses the divisional application practice back to the one existing prior to the introduction of the 24-month deadline of rule 36 EPC in 2010: a divisional application can be filed as long as the parent case has not been granted or rejected yet. A new fee schedule will be introduced with additional progressively increasing fees for divisional applications of second or later generation.

In light of this important development of the divisional application practice, EPO applicants should consider delaying the grant of pending applications to a date after April 1, 2014 where the 24-month deadline of rule 36 EPC has already expired.

For further information on the new divisional application practice and the practical demands and resulting possibilities please do not hesitate to contact the attorney's of df-mp.

to top
DEUTSCH | ENGLISH ContactDisclaimerPrivacy


Dörries Frank-Molnia & Pohlman
Patentanwälte Rechtsanwälte PartG mbB

Theatinerstrasse 16
80333 Munich
Phone: + 49 89 210 296 0
Fax:+ 49 89 210 296 33